These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 9796054)

  • 1. Enhancing activity of mycobacterial cell-derived adjuvants on immunogenicity of recombinant human hepatitis B virus vaccine.
    Koike Y; Yoo YC; Mitobe M; Oka T; Okuma K; Tono-oka S; Azuma I
    Vaccine; 1998 Dec; 16(20):1982-9. PubMed ID: 9796054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant activity of muramyl dipeptide derivatives to enhance immunogenicity of a hantavirus-inactivated vaccine.
    Yoo YC; Yoshimatsu K; Koike Y; Hatsuse R; Yamanishi K; Tanishita O; Arikawa J; Azuma I
    Vaccine; 1998; 16(2-3):216-24. PubMed ID: 9607033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of muramyl dipeptide derivatives as adjuvants on the induction of antibody response to recombinant hepatitis B surface antigen.
    Tamura M; Yoo YC; Yoshimatsu K; Yoshida R; Oka T; Ohkuma K; Arikawa J; Azuma I
    Vaccine; 1995 Jan; 13(1):77-82. PubMed ID: 7762283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Augmentation of immune responses by a muramyl dipeptide analog, MDP-Lys(L18).
    Akasaki M; Takashi T; Kita Y; Tsukada W
    Agents Actions; 1987 Oct; 22(1-2):144-50. PubMed ID: 3318323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity of Corynebacterium pseudotuberculosis and the effect of adjuvants in mice.
    Brogden KA; Cutlip RC; Lehmkuhl HD
    J Comp Pathol; 1985 Apr; 95(2):167-73. PubMed ID: 3837788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of MDP-Lys(L18) as a mucosal immunoadjuvant on protection of mucosal infections by Sendai virus and rotavirus.
    Fukushima A; Yoo YC; Yoshimatsu K; Matsuzawa K; Tamura M; Tono-oka S; Taniguchi K; Urasawa S; Arikawa J; Azuma I
    Vaccine; 1996 Apr; 14(6):485-91. PubMed ID: 8782344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigenicity study of muroctasin.
    Yamaguchi F; Hattori H; Wagai N; Tsukada W
    Arzneimittelforschung; 1988 Jul; 38(7A):1034-7. PubMed ID: 3190797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The augmentation of tumor-specific immunity using haptenic muramyl dipeptide (MDP) derivatives. I. Synthesis of a novel haptenic MDP derivative cross-reactive with Bacillus Calmette Guerin and its application to enhanced induction of tumor immunity.
    Hamaoka T; Takai Y; Kosugi A; Mizushima Y; Shima J; Kusama T; Fujiwara H
    Cancer Immunol Immunother; 1985; 20(3):183-8. PubMed ID: 2933141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunopotentiation of cattle vaccinated with a soluble Brucella abortus antigen with low LPS content: an analysis of cellular and humoral immune responses.
    Dzata GK; Wyckoff JH; Confer AW
    Vet Microbiol; 1991 Sep; 29(1):15-26. PubMed ID: 1835212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MDP-Lys(L18), a lipophilic derivative of muramyl dipeptide, inhibits the metastasis of haematogenous and non-haematogenous tumours in mice.
    Yoo YC; Saiki I; Sato K; Azuma I
    Vaccine; 1994 Feb; 12(2):175-60. PubMed ID: 8147100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of MDP-Lys(L18), a derivative of MDP, on enhancing host resistance against Hantaan virus infection in newborn mice.
    Yoo YC; Yoshimatsu K; Hatsuse R; Tamura M; Yoshida R; Tono-oka S; Arikawa J; Azuma I
    Vaccine; 1995 Oct; 13(14):1300-5. PubMed ID: 8585284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Enhancement of the activity of hepatitis B virus vaccine by association with murabutide].
    Audibert F; Przewlocki G; Lefrancier P; Choay J; Chedid L
    C R Seances Acad Sci III; 1982 Nov; 295(10):611-4. PubMed ID: 6218866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The adjuvant effect of a muramyl dipeptide (MDP) analog on temperature-sensitive Salmonella mutant vaccine.
    Onozuka K; Shinomiya H; Cho N; Saito-Taki T; Nakano M
    Int J Immunopharmacol; 1989; 11(7):781-7. PubMed ID: 2689364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetic immunoadjuvants: application to non-specific host stimulation and potentiation of vaccine immunogenicity.
    Azuma I
    Vaccine; 1992; 10(14):1000-6. PubMed ID: 1471423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycobacterial cell-wall skeleton as a universal vaccine vehicle for antigen conjugation.
    Paik TH; Lee JS; Kim KH; Yang CS; Jo EK; Song CH
    Vaccine; 2010 Nov; 28(50):7873-80. PubMed ID: 20937311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brucella abortus vaccines: comparison of protection provided by immunopotentiated 45/20 bacterins and live strain 19 vaccine in guinea pigs.
    Woodard LF; Toone NM; Jasman RL
    Am J Vet Res; 1981 Nov; 42(11):1959-62. PubMed ID: 6802042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of BCG cell wall-induced delayed-type hypersensitivity by pretreatment with killed BCG: induction of nonspecific suppressor T cells by the adjuvant portion (MDP) and of specific suppressor T cells by the antigen portion (TAP).
    Kato K; Yamamoto K; Kimura T; Azuma I; Askenase PW
    J Immunol; 1984 Jun; 132(6):2790-5. PubMed ID: 6202761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of muramyl dipeptide, trehalose dimycolate, and dimethyl dioctadecyl ammonium bromide as adjuvants in Brucella abortus 45/20 vaccines.
    Woodard LF; Toone NM; McLaughlin CA
    Infect Immun; 1980 Nov; 30(2):409-12. PubMed ID: 6777304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative analysis of the immunostimulatory properties of different adjuvants on the immunogenicity of a prototype parainfluenza virus type 3 subunit vaccine.
    Ewasyshyn M; Caplan B; Bonneau AM; Scollard N; Graham S; Usman S; Klein M
    Vaccine; 1992; 10(6):412-20. PubMed ID: 1317984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune response to porin in cattle immunized with whole cell, outer membrane, and outer membrane protein antigens of Brucella abortus combined with trehalose dimycolate and muramyl dipeptide adjuvants.
    Winter AJ; Verstreate DR; Hall CE; Jacobson RH; Castleman WL; Meredith MP; McLaughlin CA
    Infect Immun; 1983 Dec; 42(3):1159-67. PubMed ID: 6315592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.